Angiotensin-converting enzyme inhibition or angiotensin receptor blockade in hypertensive diabetics?

Gozewijn D. Laverman; Piero Ruggenenti; Giuseppe Remuzzi

doi:10.1007/s11906-003-0080-3

Back

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article1989

Angiotensin-Converting Enzyme Inhibition Ameliorates the Defect in Glomerular Size Selectivity in Hyponatremic Hypertensive Syndrome

Andrea Remuzzi, Arrigo Schieppati, Cristina Battaglia, Giuseppe Remuzzi

Article2024

Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers for Advanced Chronic Kidney Disease

Elaine Ku, Lesley A. Inker, Hocine Tighiouart, Charles E. McCulloch, Ogechi M. Adingwupu, Tom Greene, Raymond O. Estacio, Mark Woodward, Dick de Zeeuw, Julia B. Lewis, Thierry Hannedouche, Tazeen H. Jafar, Enyu Imai, Giuseppe Remuzzi, Hiddo J.L. Heerspink, Fan Fan Hou, Robert D. Toto, Philip Kam‐Tao Li, Mark J. Sarnak

Article2004

ACE Inhibition versus Angiotensin Receptor Blockade

Gozewijn D. Laverman, Giuseppe Remuzzi, Piero Ruggenenti

Article1996

Comparison of the effects of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade on the evolution of spontaneous glomerular injury in male MWF/Ztm rats.

Andrea Remuzzi, Barbara Malanchini, Cristina Battaglia, Tullio Bertani, Giuseppe Remuzzi

Article2005

Angiotensin-Converting Enzyme Inhibition and Renal Protection in Nondiabetic Patients

Carlos Chiurchiu, Giuseppe Remuzzi, Piero Ruggenenti